CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.9358
+0.0108 (1.17%)
Apr 29, 2025, 1:03 PM EDT - Market open

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.251.520.481.1
Cash & Short-Term Investments
3.251.520.481.1
Cash Growth
113.76%219.73%-56.68%-
Prepaid Expenses
0.270.370.230.26
Restricted Cash
0.070.0841.67-
Other Current Assets
0.11---
Total Current Assets
3.711.9742.371.36
Property, Plant & Equipment
1.993.16--
Long-Term Deferred Tax Assets
---0.02
Long-Term Deferred Charges
0.5---
Other Long-Term Assets
---178.7
Total Assets
6.215.1342.37180.08
Accounts Payable
4.511.671.650.01
Accrued Expenses
1.910.1400.08
Short-Term Debt
-0.60.65-
Current Portion of Leases
0.880.77--
Current Income Taxes Payable
--0.6-
Other Current Liabilities
0.110.3227.84-
Total Current Liabilities
7.43.5130.750.1
Long-Term Leases
0.71.58--
Other Long-Term Liabilities
--22.62187.65
Total Liabilities
8.15.0853.37187.75
Common Stock
0000
Additional Paid-In Capital
67.141.03--
Retained Earnings
-70.92-43.09-11-7.67
Comprehensive Income & Other
-1.3---
Total Common Equity
-5.07-42.06-11-7.67
Shareholders' Equity
-1.890.04-11-7.67
Total Liabilities & Equity
6.215.1342.37180.08
Total Debt
1.582.940.65-
Net Cash (Debt)
1.68-1.42-0.171.1
Net Cash Per Share
3.28--0.7711.39
Filing Date Shares Outstanding
5.380.154.624.78
Total Common Shares Outstanding
2.420.064.624.78
Working Capital
-3.69-1.5411.621.26
Book Value Per Share
-2.10-673.33-2.38-1.60
Tangible Book Value
-5.07-42.06-11-7.67
Tangible Book Value Per Share
-2.10-673.33-2.38-1.60
Machinery
2.552.55--
Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q